DCF — ST. ALEXIUS MEDICAL CENTER
Enterprise Value: $-237.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-237.0M
Enterprise Value
$-83.0M
PV of Cash Flows
$-154.0M
PV of Terminal Value
$-248.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $386.3M | $-10.4M | -3.0% | $-26.7M | $-24.3M |
| Year 2 | $397.9M | $-6.7M | -2.0% | $-23.6M | $-19.5M |
| Year 3 | $409.8M | $-2.8M | -1.0% | $-20.2M | $-15.2M |
| Year 4 | $422.1M | $-0.8M | -0.0% | $-18.7M | $-12.8M |
| Year 5 | $434.8M | $0.3M | 0.0% | $-18.1M | $-11.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-237.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$375.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03190756780569686
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5